Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products ...

As of 9:45:59 AM EST. Market Open. Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his team of dealmakers can juggle them.

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for 2025. Sales in 2024 totaled $68.7 billion, which beat the Zacks Consensus ...

BRISK RETAIL SALES OF DIRECTLY OPERATED STORES IN Q4 (UP 5.7%) NON-FINANCIAL PERFORMANCE RATING UP 3 POINTS Paris, 30 January 2025 ROCHE BOBOIS SA (ISIN: FR0013344173 - Ticker symbol: RBO), the ...

Roche achieved a sales growth of 7% (3% in CHF) in 2024, citing strong demand for pharmaceutical products. As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor ...

ROCHE BOBOIS SA (ISIN: FR0013344173 - Ticker symbol: RBO), the global benchmark on the high-end home furnishings market and French Art de Vivre, today announces full-year revenue of €414.0m for 2024, ...